Novel antihyperglycaemic drugs and prevention of chronic obstructive pulmonary disease exacerbations among patients with type 2 diabetes: population based cohort study

OBJECTIVE: To determine whether the use of glucagon-like peptide 1 (GLP-1) receptor agonists, dipeptidyl peptidase 4 (DPP-4) inhibitors, and sodium-glucose co-transporter-2 (SGLT-2) inhibitors, separately, is associated with a decreased risk of exacerbations of chronic obstructive pulmonary disease...

Descripción completa

Detalles Bibliográficos
Autores principales: Pradhan, Richeek, Lu, Sally, Yin, Hui, Yu, Oriana H Y, Ernst, Pierre, Suissa, Samy, Azoulay, Laurent
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group Ltd. 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9623550/
https://www.ncbi.nlm.nih.gov/pubmed/36318979
http://dx.doi.org/10.1136/bmj-2022-071380

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9623550/
https://www.ncbi.nlm.nih.gov/pubmed/36318979
http://dx.doi.org/10.1136/bmj-2022-071380

Ejemplares similares